Sun et al. demonstrated that CD300a promotes upregulation of PECAM1 and ADCY7, thereby activating the AKT/mTOR signaling pathway, which may support AML cell survival and proliferation [80]. Here, PECAM1 is linked to acute myeloid leukemia.